| Revenue growth | Revenue +42% YoY to ₹296 Cr; battery contributed ₹37 Cr. |
|---|---|
| Margins | Standalone EBITDA margin 18.6%; chemicals guided 18–20%; consolidated diluted by Ionics. |
| Demand visibility | Strong US/India demand; POs in hand; customer approvals still pending. |
| Management confidence | Overly upbeat; 'robust all round' despite PAT ₹8 Cr; defers detail. |
Growth
Revenue +42%, EBITDA +51%; battery ₹37 Cr vs ₹5 Cr, but Neogen Ionics fixed-cost drag dilutes consolidated margins.
Outlook
Battery ₹250–300 Cr FY27; base business ₹1,100+ Cr FY27, ₹1,200–1,300 Cr FY28; net debt ₹1,300–1,500 Cr FY28.
Risks
Inventory build (180-day target); no electrolyte take-or-pay; US/India policy dependence; ₹1,095 Cr net debt.
Last quarter's promises, checked
Delivered
- Standalone EBITDA margin 18%±1–1.5% → 18.6% (= BEAT)
Partly delivered
- Battery FY27 ₹300 Cr → Q1 ₹37 Cr; FY27 now ₹250–300 Cr (= PARTIAL)
- Post-QIP net debt ₹1,000–1,500 Cr → ₹1,095 Cr, QIP-conditional (= PARTIAL)
Missed
- Organolithium incremental capex ₹10–15 Cr → ₹45 Cr capex, 300→600 TPA (= MISS)
- Insurance recovered+receivable ₹350 Cr → ₹316 Cr (= MISS; definitions may differ)
Earnings Call Transcript filed with NSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,095.40
- Market cap
- ₹6,295 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 155.7×Sector 33.6×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Neogen Chemicals Capacity Expansion: ₹45 Cr Investment
Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.
- Value
- ₹45.00 Cr
- Execution
- By end of next financial year
- manufacturing capacity
- 600.0 MTPA
Neogen Chemicals Other Announcement
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
Neogen Chemicals Q2 FY27 Results: Net Profit ₹8.2 Cr, Up 141.2% YoY
Neogen Chemicals Ltd reported revenue from operations of ₹296 Cr (+41.8% YoY) and net profit of ₹8.2 Cr (+141.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.2 Cr · +141.2% YoY